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ABSTRACT Site-specific proteases play critical roles in
regulating many cellular processes. To identify novel site-
specific proteases, their regulators, and substrates, we have
designed a general reporter system in Saccharomyces cerevisiae
in which a transcription factor is linked to the intracellular
domain of a transmembrane protein by protease cleavage
sites. Here, we explore the efficacy of this approach by using
caspases, a family of aspartate-specific cysteine proteases, as
a model. Introduction of an active caspase into cells that
express a caspase-cleavable reporter results in the release of
the transcription factor from the membrane and subsequent
activation of a nuclear reporter. We show that known caspases
activate the reporter, that an activator of caspase activity
stimulates reporter activation in the presence of an otherwise
inactive caspase, and that caspase inhibitors suppress
caspase-dependent reporter activity. We also find that, al-
though low or moderate levels of active caspase expression do
not compromise yeast cell growth, higher level expression
leads to lethality. We have exploited this observation to isolate
clones from a Drosophila embryo cDNA library that block
DCP-1 caspase-dependent yeast cell death. Among these
clones, we identified the known cell death inhibitor DIAP1. We
showed, by using bacterially synthesized proteins, that gluta-
thione S-transferase–DIAP1 directly inhibits DCP-1 caspase
activity but that it had minimal effect on the activity of a
predomainless version of a second Drosophila caspase, drICE.
Site-specific proteolysis plays a critical role in regulating a
number of cellular processes. An important class of site-
specific proteases are a group of cysteine proteases known as
caspases (1). Extensive genetic and biochemical evidence
indicates that caspases play roles as cell death signaling and
effector molecules in a number of different contexts, thus
making them attractive potential therapeutic targets. Caspases
identified to date have been found primarily based on homol-
ogy to the Caenorhabditis elegans caspase CED-3 and mam-
malian caspase 1 and through biochemical purification (re-
viewed in refs. 2–5). Viral and cellular activators and inhibitors
of caspase function also have been identified in genetic and
biochemical screens for regulators of apoptosis (reviewed in
refs. 6–8). These approaches to isolating caspases and their
regulators are limited by the fact that some proteases that
cleave a caspase target site and their regulators may not share
primary sequence homology with the proteins identified to
date or they may be expressed only in specific tissues with
limited availability for biochemical purification. Furthermore,
it is clear that caspases regulate processes other than cell death,
including cytokine secretion in mammals (9–13) and cell
proliferation and oogenesis in Drosophila (14, 15). It seems
likely, given the early stage of the field, that more roles exist.
Caspases and caspase regulators involved in these processes
may be missed in screens that focus strictly on cell death-
related phenotypes. Thus, molecules that possess caspase or
caspase regulatory activity may not have been identified yet.
As an alternative approach to identifying novel caspases or
caspase regulators, it would be useful to have assays for caspase
function that are based strictly on protease activity.
Because of the importance of site-specific proteolysis, we
sought to develop a versatile system that would allow the
identification of novel site-specific proteases, regulators of the
activity of known site-specific proteases, or their substrates.
Because caspase cleavage sites have been well defined, and
activators and inhibitors of caspases have been identified, we
set out to establish a prototype system that would allow positive
selection for caspase-like proteases, their activators, and their
inhibitors. Our approach to identifying these molecules uses
reporters for caspase activity that function in living cells.
Yeast, though eukaryotic, lacks many of the specialized pro-
teolytic systems found in cells of higher eukaryotes. Thus, it
constitutes an ideal background in which to carry out function-
based screens for these proteases, their regulators, and their
targets. Reporters for the activity of specific proteases in
bacteria and eukaryotes have been developed by using several
strategies that involve cleavage-dependent alterations in the
activity of specific proteins (16–21). To visualize caspase
activity, we created a fusion protein in which a transcription
factor is linked to the intracellular domain of a transmembrane
protein by caspase cleavage sites. Expression of this protein in
yeast, in the presence of an active caspase, should result in
release of the transcription factor from the membrane, fol-
lowed by transcriptional activation of a reporter. As described
below, using such a reporter system, we can visualize caspase
activity in yeast and can identify proteins that act as caspase
activators and inhibitors. Caspase inhibitors also can be iden-
tified by virtue of their ability to suppress caspase overexpres-
sion-dependent yeast cell death.
MATERIALS AND METHODS
Constructs
Yeast Strains. The W303a strain (MATa, can1–100, leu2–
3,-112, his3–11,-15, trp1–1, ura3–1, ade2–1) was used to mon-
itor caspase activity by using the lacZ reporter system. EGY48
(MATa, ura3, trp1, his3, LexAop6-LEU2) (Invitrogen) was
used to monitor caspase-dependent cell killing.
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Construction of Caspase Target Site Fusion Proteins. The
reporter, CLBDG6, was generated by using PCR and standard
techniques (details provided on request). This protein consists
of, from N to C termini, amino acids 1–401 of a type 1
transmembrane protein, human CD4 (22), a linker consisting
of six tetrapeptide caspase target sites that bracket the spec-
ificity of known caspases and granzyme B (23)—DEVDG-
WEHDG-IEHDG-IETDG-DEHDG-DQMDG—, each of
which is followed by a glycine residue, which acts as a stabi-
lizing residue in the N-end rule degradation pathway in yeast
(reviewed in refs. 24), and finally, a transcription factor
containing the LexA DNA binding domain (25). A second
construct, designated CLBGG6, was generated that encodes a
protein identical to CLBDG6 except that the essential P1
aspartates of the six caspase cleavage sites are replaced with
glycines, rendering them nonfunctional.
Construction of Yeast Expression Plasmids. Plasmids for
expression of genes in yeast were derived from the pRS series
(26). To express genes in yeast under galactose-inducible
control, we used two GAL1 promoter fragments: a long
version, extending from base 1–815, called GALL, and a
shorter and somewhat weaker version, extending from base
406–815, called GALS (27). The yeast actin terminator, bases
2,107–2,490 (GenBank accession no. L00026), was used for all
constructs. GALL promoter and actin terminator fragments
were inserted into pRS313 (HIS3), pRS314 (TRP1), and
pRS315 (LEU2), generating pGALL-(HIS3), pGALL-
(TRP1), and pGALL-(LEU2). CLBDG6 and CLBGG6 coding
regions were cloned into pGALL-(TRP1). GALS promoter
and actin terminator fragments were inserted into pRS315,
generating pGALS-(LEU2). To express genes under the con-
trol of the copper-inducible CUP1 promoter, we used a
promoter fragment extending from bases 1,079–1,533 of the
CUP1 locus (GenBank accession no. K02204). Site-directed
mutagenesis was used to mutate the CUP1 promoter to prevent
activation in response to glucose starvation (28). The mutated
CUP1 promoter and actin terminator fragments were inserted
into pRS315 (LEU2), generating pCUP1-(LEU2).
The coding region for the C. elegans caspase CED-3 (29) was
introduced into pCUP1-(LEU2). Site-directed mutagenesis
was used to generate an inactive version of CED-3 in which the
active site cysteine was changed to serine (CED-3CS). Full
length human caspase 7 (caspase 7FL) (30), caspase 7 lacking
the N-terminal 53-aa prodomain (caspase 753), and the caspase
8 isoform corresponding to MACHa2 (31) or Mch5 (32)
(caspase 8FL) were introduced into pCUP1-(LEU2). Full
length DCP1 (14) was introduced into pGALS-(LEU2) and
pGALL-(LEU2). Site-directed mutagenesis was used to
change the active site cysteine to serine (DCP-1CS). The
resulting full length coding region was introduced into
pGALL-(LEU2). Full length drICE (33) was inserted into
pGALL-(LEU2). Full length human caspase 9 (34, 35) was
introduced into pGALL-(LEU2). The region encoding amino
acids 1–530 of Apaf-1 (36) (Apaf-1530) was introduced into
pGALL-(HIS3). Full length DIAP1 (FLDIAP1) and a version
of DIAP1 C-terminally truncated following residue 381
(DIAP1BIR) (37) were introduced into pGALL-(HIS3). The
mouse IAP MIHA (38) and baculovirus p35 (39) were intro-
duced into pGALL-(HIS3).
Yeast Transformation and Characterization. Plasmids were
introduced into yeast by lithium acetate transformation. For
caspase activity assays in which lacZ expression was monitored,
yeast were transformed with pSH18–34 (URA3) (Invitrogen),
which carries a LexA-responsive lacZ gene. These cells then
were transformed with either pGALL-CLBDG6-(TRP1) or
pGALL-CLBGG6-(TRP1). Caspase expression plasmids or an
empty expression vector were introduced into these back-
grounds and were characterized as described below. For
caspase activation and inhibition assays, a fourth plasmid also
was introduced, either expressing Apaf-1530, p35, or MIHA or
with no insert. To carry out X-gal filter assays for b-galacto-
sidase (b-gal) activity, transformants were plated on selective
plates with glucose (2%) as the sugar source. After 3 days,
duplicate colonies were picked and resuspended in 1 ml of
sterile TriszEDTA (pH 8.0). One microliter of each sample was
streaked on a minimal medium glucose plate. After 2 days, a
nylon membrane was used to lift the streaked yeast (yeast side
upwards) onto a complete medium plate containing 2% ga-
lactose and 1% raffinose (galyraf media) and 3 mM copper
sulfate. After various periods of induction, the filters were
processed for X-gal staining (40). To quantitate b-gal activity,
three tubes of liquid selective galyraf medium were inoculated
with single colonies from each transformation plate, were
grown for 24 hr, then were diluted 1:10 into fresh galyraf
selective medium containing the indicated concentration of
copper sulfate and were grown for a further 10 hr. o-nitro-
phenyl-b-D-galactoside assays were performed as described by
Miller (41). To assay caspase-dependent cell death and pro-
tection by inhibitors, colonies carrying the relevant plasmids
were streaked from 2% glucose selective media plates onto
galyraf selective media plates. The plates were photographed
after 3 days.
Expression and Purification of Recombinant Drosophila
IAPs and Caspases. The DIAP1 coding region was amplified
by PCR using primers that generated an N-terminal myc
epitope (EQKLISEEDL) and was introduced into the gluta-
thione S-transferase (GST) expression vector pGEX4T-1
(Amersham Pharmacia). The GST-myc-DIAP1 fusion protein
was expressed in Escherichia coli strain BL21(DE3)pLysS
(Novagen) and was affinity-purified on glutathione-
Sepharose. The eluted protein was dialyzed against buffer A
(25 mM Tris, pH 8.0y50 mM NaCly10 mM DTT). After
dialysis, the protein was frozen in aliquots after addition of
glycerol to 10%.
DCP-1, initiating at codon 31 (DCP-131), was introduced
into pET23a(1) (Novagen), generating a DCP-131-His6 fusion.
A similar procedure was used to generate a drICE-His6 fusion
protein in which DrICE initiates at codon 81 (drICE81-His6).
DCP-131-His6 and drICE81-His6 were expressed in the E. coli
strain BL21(DE3)pLysS. Protein expression and affinity pu-
rification from the soluble fraction were carried out using
ProBond resin (Invitrogen). Eluted protein was dialyzed
against buffer A and subsequently was snap frozen in buffer A
containing 10% glycerol.
Drosophila cDNA Library Construction and DCP-1 Inhib-
itor Screening. Drosophila embryonic polyA1 mRNA
(CLONTECH) was converted into cDNA by using a Super-
script cDNA synthesis kit (GIBCO). cDNAs larger than 600 bp
were ligated into a modified version of pGALL-(HIS3) in
which the polylinker was expanded to contain XhoI and NotI
sites. ElectroMax DH10B cells (GIBCO) were transformed
with the ligation mix and were used to amplify the library,
which contained 5 3 106 primary transformants.
W303a yeast carrying pGALL-DCP-1-(LEU2) were trans-
formed with 26 mg of library plasmid DNA, were grown in
yeast extractypeptoneydextrose for 3 hr, were washed twice to
remove glucose, and were plated on galyraf selective plates. A
total of 140,000 transformants were screened. Colonies were
picked after 4 days of growth at 30°C. PCR was carried out on
DNA isolated from individual colonies by using DIAP1-
specific primers.
In Vitro Protease Assays. DCP-131-His6 and DrICE81-His6
caspase activity were measured fluorometrically by following
the release of 7-amino-4-trif luoromethyl-coumarin (AFC)
from Ac-DEVD-AFC (Enzyme Systems Products, Livermore,
CA) using the fmax fluorescence microplate reader (Molec-
ular Devices) with an excitation wavelength of 405 nm and an
emission wavelength of 510 nm. The ability of GST-DIAP1 to
inhibit caspase activity was determined from caspase activity
assay progress curves in which substrate hydrolysis (100 mM)
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by DCP-131-His6 (0.2 nM) or drICE81-His6 (0.62 nM) was
measured in the presence of GST (0.48 mM) or GST-
mycDIAP1 (0.16 mM), in caspase activity buffer (50 mM
Hepes, pH 7.5y100 mM NaCly1 mM EDTAy0.1% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonatey
10% sucrosey5 mM DTT).
RESULTS AND DISCUSSION
Our approach to monitoring caspase activity in vivo was to
create cells in which caspase activity stimulates transcriptional
activation of a reporter. We created a fusion protein substrate
for caspase cleavage in which the transcription factor LexA-
B42 (LB) is linked to the truncated cytoplasmic domain of a
membrane protein, CD4 (C), by a short linker (DG6) consist-
ing of six different caspase cleavage sites that bracket the
specificities of known caspases and the serine protease gran-
zyme B, which cleaves caspases and other targets at sites of
similar sequence (Material and Methods for details). When this
molecule, referred to as CLBDG6, is expressed in a reporter
strain in which a LexA-dependent promoter drives lacZ ex-
pression (LexAyb-gal reporter), levels of b-gal activity should
depend on the presence of an active caspase able to cleave one
or more of the introduced target sites, thereby releasing
LexA-B42 from membrane association. (Fig. 1 A and B).
A Reporter for Caspase Activity in Yeast. We introduced
CLBDG6 into the LexAyb-gal reporter strain in a plasmid,
pGALL-CLBDG6, in which expression is induced in response
to galactose. We introduced into this background a copper-
inducible expression plasmid, pCUP1, containing either no
insert or different versions of the caspase CED-3. Transfor-
mants initially were streaked on glucose medium. Colonies
from these streaks then were replica plated onto galyraf
medium containing 3 mM copper to induce expression of
CLBDG6 and from the pCUP1 plasmid. After 12 hr of
induction, levels of b-gal activity were determined by using an
X-gal assay in which cells that do not express b-gal remain
white whereas those that do turn shades of blue. Reporter cells
that expressed CLBDG6 alone remained white in this assay
(Fig. 2A), indicating that yeast contains negligible amounts of
proteases capable of cleaving caspase target sites under stan-
dard growth conditions. However, when expression of the C.
elegans caspase CED-3 (pCUP1-CED-3) was induced, a high
level of b-gal activity was observed (Fig. 2A), which increased
in a copper concentration-dependent manner (Fig. 2B). Of
importance, caspase activity was required for reporter activa-
tion because expression of an inactive CED-3 mutant in which
the active site cysteine had been changed to serine (CED-3CS)
did not result in b-gal expression (Fig. 2 A). Finally, expression
of wild-type CED-3 in a reporter strain in which the essential
P1 aspartates of the caspase target sites in CLBDG6 had been
mutated to glycines (CLBGG6) (Fig. 1C) did not result in b-gal
activity (Fig. 2A), arguing that the CED-3-dependent induc-
tion of b-gal activity was a direct result of cleavage of CLBDG6
at the caspase target sites.
These results establish that yeast can be used as a cell-based
reporter system for caspase activity. In order for a caspase to
be identified in this assay, the caspase must be active in yeast.
Physiological activation of caspases occurs through multiple
mechanisms, including recruitment and oligomerization at the
plasma membrane, cleavage by caspases or other proteases
able to recognize a caspase target site, interactions with
members of the CED-4yApaf-1 family of proteins, and auto-
FIG. 1. A genetic system for monitoring caspase activity in yeast
using a transcriptional reporter. Yeast were created that express a
chimeric type-1 transmembrane protein (CLBDG6) in which the
N-terminal signal sequence and transmembrane domain (CD4) is
followed by a linker consisting of six tetrapeptide caspase target sites
(indicated in bold) that bracket the specificity of known caspases and
granzyme B (23)—DEVDG-WEHDG-IEHDG-IETDG-DEHDG-
DQMDG—each of which is followed by a glycine residue, which acts
as a stabilizing residue in the N-end rule degradation pathway in yeast
(reviewed in ref. 24). C-terminal to the caspase target site linker is a
transcription factor domain, LexA-B42. The LexA-dependent tran-
scriptional reporter consists of LexA binding sites (LexA UAS) and a
promoter (P) upstream of the bacterial lacZ gene (lacZ) (A). The cells
in A act as caspase activity reporters because expression of an active
caspase results in CLBDG6 cleavage at the caspase target sites,
releasing LexA-B42, which enters the nucleus and activates lacZ
transcription (B). A version of CLBDG6 in which the P1 aspartates are
changed to glycines (CLBGG6) cannot be cleaved by caspases. Cells
expressing CLBGG6 act as false positive reporters for molecules that
activate lacZ expression independent of cleavage at caspase target site
(C). If cells in B express a caspase inhibitor as well as an active caspase,
caspase activity, and thus caspase-dependent release of LexA-B42, is
inhibited, and b-gal levels are decreased compared with cells that
express the caspase alone (D).
FIG. 2. Yeast expressing CLBDG6 act as reporters for CED-3
caspase activity. W303a yeast were transformed with pSH18–34, which
carries a LexA-responsive lacZ transcriptional cassette (the LexAyb-
gal reporter strain). These cells were transformed with pGALL
expression plasmids carrying CLBDG6 (DG6) or CLBGG6 (GG6).
These cells also carry a copper-inducible pCUP1 plasmid, which
contains either wild-type CED-3 (CED-3), an inactive C to S mutant
version of CED-3 (CED-3 C-S), or nothing. Duplicate colonies from
each transformation were streaked onto galyraf medium to induce
GAL1-dependent expression of the caspase substrates and then were
lifted onto complete media plates with 3 mM copper sulfate to induce
caspase expression. After a 12-hr induction, an X-gal assay was
performed on the filter. Only cells expressing CLBDG6 and wild-type
CED-3 have significant b-gal activity (A). Cultures from three trans-
formants carrying pSH18–34, pGAL-CLBDG6, and either the empty
pCUP1 vector or pCUP1-CED-3 were grown to stationary phase, then
were diluted into medium containing the indicated levels of copper
sulfate and grown for a further 10 hr. o-nitrophenyl-b-D-galactoside
assays were performed, and b-gal activity was determined. b-gal
activity in the CED-3-expressing cells increased as a function of copper
concentration (filled circles, CED-3). No b-gal activity was found in
the cultures carrying only the empty pCUP1 vector (open boxes,
vector) (B).
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activation. In some cases, overexpression alone is sufficient to
induce autoactivation whereas, in other cases, significant ac-
tivation requires interactions with other proteins (reviewed in
refs. 2–5). Thus, it is likely that only proteases in which the
primary translation product is active, or in which the protease
is able to autoactivate, will be identified in the simplest
reporter-based caspase screen. However, more complex
screens for caspases that can activate after forced oligomer-
ization or association with potential caspase activators (42–46)
can be envisioned. We have tested several other caspases in this
reporter system. Expression of mammalian caspase 753 (below)
and full length caspase 8 (data not shown) resulted in reporter-
dependent lacZ expression. Expression of human caspase 3,
caspase 9, or Drosophila drICE failed to activate reporter
expression (data not shown), even though active forms of these
caspases are known to efficiently cleave peptides with the same
sequence as the target sites introduced into CLBDG6 (23, 33).
Moreover, although overexpression of wild-type but not an
inactive mutant of CED-3 induced yeast cell death (below),
similar overexpression of caspase 3, caspase 9, or drICE had no
effect on cell growth. Based on these observations, it is likely
that, in yeast, the procaspase forms of these caspases do not
autoprocess to generate active caspase heterodimers. This
result is expected: Caspase 9 is thought to function as an
upstream caspase, in which a major mechanism of activation
requires association with Apaf-1 (42, 43), whereas caspase-3 is
thought to act as a downstream caspase, in which a principal
mechanism of activation is cleavage by other caspases (re-
viewed in refs. 2–5). drICE activation may be regulated by
either of these mechanisms.
Activators of Caspase-Dependent Reporter Activation. The
fact that certain caspases do not activate in yeast suggests that
it should be possible to screen for their activators as molecules
that induce reporter expression in the presence of an otherwise
inactive caspase. To demonstrate this, we carried out an
experiment in which caspase activity was monitored in yeast
that expressed full length caspase 9, alone or in combination
with a fragment of Apaf-1 that is constitutively active with
respect to caspase 9 processing activity in vitro (43). Transfor-
mants of the pGALL-CLBDG6 LexAyb-gal reporter strain
were generated that carried either two empty vectors, an empty
vector and pGALL-Apaf-1530, an empty vector and pGALL-
caspase 9, or pGALL-caspase 9 and pGALL-Apaf-1530. Trans-
formants initially were streaked on glucose medium. Colonies
from these streaks then were replica plated onto galyraf
medium to induce GALL-dependent expression. After 16 hr of
induction, levels of b-gal activity were determined by using an
X-gal assay. Reporter cells that expressed either nothing,
caspase 9, or Apaf-1530 alone remained white in this assay,
indicating that caspase activity was not induced (Fig. 3).
However, colonies that expressed both caspase 9 and Apaf-1530
showed robust b-gal activity, suggesting the occurrence of
Apaf-1530-mediated activation of the otherwise inactive pro-
caspase 9 (Fig. 3).
We used b-gal activity, as assayed after replica plating of
colonies, as the basis for our caspase reporter assay because
caspases are expressed conditionally after replica plating. Thus,
their identification is feasible even if their expression is toxic to
cells. However, caspase activity screens also can be adapted to
positive, survival-based screening assays by requiring LexA-
dependent expression of a yeast auxotrophic marker such as HIS3
or URA3. False positives in these caspase reporter assays could
arise because introduced proteins bind to the LexA binding sites
and activate transcription directly or because they encode pro-
teases that cleave CLBDG6, but not at the caspase target sites.
Both classes of false positives can be identified by the fact that they
should still activate lacZ expression when introduced into a
LexAyb-gal reporter strain that expresses CLBGG6, the false
positive reporter strain (Fig. 1C).
Suppression of Caspase-Dependent Reporter Activation by
Caspase Inhibitors. Once a reporter for the activity of a
specific caspase has been established in yeast, it should be
possible to screen for inhibitors of that activity by identifying
cells that express the protease but in which reporter activity is
repressed (Fig. 1D). Here, we demonstrate the feasibility of
this approach by showing that two different families of caspase
inhibitors, exemplified by baculovirus p35 and the murine IAP
MIHA, suppress caspase-dependent reporter activation. p35 is
a broad specificity caspase inhibitor in which inhibition is
associated with cleavage (reviewed in ref. 6). The IAPs
comprise a second class of caspase inhibitors distinct from p35
in which cleavage of the inhibitor does not play a role. IAPs
originally were identified in the baculovirus system by virtue of
their ability to substitute for baculovirus p35 as suppressers of
viral infection-induced cell death (47). IAP homologs have
now been found in other viruses, Drosophila, C. elegans,
mammals and yeast and are characterized by one or more
N-terminal repeats known as baculovirus IAP repeats (BIRs).
Many also have a C-terminal RING finger motif (reviewed in
refs. 6–8 and 48). Several mammalian IAPs—XIAP, cIAP1,
and cIAP2—bind to and directly inhibit caspases-3 and -7 in
vitro (49, 50). We introduced pGALL-CLBDG6 and either an
empty pCUP1 plasmid or a pCUP plasmid containing CED-3
or caspase 753 into the LexAyb-gal reporter strain along with
either an empty pGALL expression vector, a pGALL expres-
sion vector carrying p35, or a pGALL expression vector
carrying MIHA (murine XIAP). Transformants were grown in
galactose-containing medium to induce expression of
CLBDG6 and the caspase inhibitor and then were transferred
to medium containing galactose and 3 mM copper to induce
expression of the caspase. b-gal activity was determined after
a 10-hr copper induction. As shown in Fig. 4 A and B,
expression of p35 inhibited both CED-3 and caspase 753
activity '5-fold. A similar though somewhat weaker ('2-fold)
inhibition of caspase 753 activity was seen in the presence of
MIHA (Fig. 4B), indicating that caspase-IAP interactions can
be detected in this assay.
Caspase Overexpression-Dependent Yeast Cell Death. In
the above assay, the presence of a caspase inhibitor is indicated
by a decrease in b-gal activity. However, in many situations, it
would be useful if caspase inhibition was coupled to a positive
reporter output. A direct approach to identifying caspase
inhibitors rests on the observation that high level expression of
active caspase causes yeast cell death. Low level expression of
the Drosophila caspase DCP-1 from the induced CUP-1 pro-
moter did not significantly compromise yeast cell growth.
Higher level expression from the GAL promoter, however, did
FIG. 3. Expression of Apaf-1530 induces caspase 9-dependent
reporter activation. W303a containing pSH18–34 and pGALL-
CLBDG6 were transformed with pGALL plasmids to carry either two
empty pGALL vectors, Apaf-1530 and an empty pGALL vector,
caspase 9 and an empty pGALL vector, or Apaf-1530 and caspase 9.
Two colonies from each transformation were streaked onto selective
glucose medium plates, were grown for several days, and then were
replica plated onto complete galyraf medium. After 16 hr, an X-gal
assay was performed. Only cells expressing both Apaf-1530 and caspase
9 show significant b-gal activity.
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result in cell lethality. Cells were able to grow on galactose-
containing media if they carried an empty pGALL expression
vector but not if they carried a pGALL-DCP-1 expression
construct (Fig. 5A). This effect of DCP-1 expression was
attributable to cell death because a .250-fold decrease in the
number of colony forming units was seen when cells carrying
the pGALL-DCP-1 expression plasmid were grown for 12 hr
in liquid galyraf medium, thus inducing high level DCP-1
expression, and then were plated on glucose-containing me-
dium (data not shown). Of importance, GALL-DCP-1-
expression-dependent cell killing depended on caspase activity
because expression of an inactive mutant form of DCP-1
(DCP-1 C285S) did not cause cell death (Fig. 5A). Caspase-
mediated cell death in yeast may be a general phenomenon
because other caspases that are active in yeast, including full
length CED-3, full length caspase 8, and caspase 753, block
colony formation when expressed under control of the strong
GALL promoter (data not shown).
Caspase Inhibitors Suppress Caspase Overexpression-
Dependent Cell Death. To demonstrate that caspase inhibitors
can be identified as proteins that restore cell viability to yeast
expressing an active caspase, we carried out an experiment in
which the broad specificity caspase inhibitor p35 was coex-
pressed with full length DCP-1. We introduced pGALL ex-
pression plasmids that either had no insert, or that carried p35,
into cells carrying a pGALS-DCP-1 plasmid. Cells from col-
onies carrying these plasmids were grown on glucose-
containing media and then were streaked onto galyraf media
to induce expression of the caspase and the potential inhibitor.
As shown in Fig. 5B, pGALS-dependent expression of DCP-1
in the presence of an empty pGALL expression vector resulted
in no cell growth. In contrast, coexpression of baculovirus p35
with DCP-1 resulted in a dramatic rescue of cell growth.
To determine whether a yeast survival-based screen can be
used to identify novel caspase inhibitors, we transformed yeast
carrying pGALS-DCP-1 with a Drosophila pGALL embryonic
cDNA expression library and plated these cells on galyraf
medium. In a screen of '1.4 3 105 transformants, '50
positives were obtained. These were tested by PCR, and all
were found to correspond to DIAP1, which was originally
identified as an inhibitor of reaper or hid overexpression-
induced, caspase-dependent cell death in the fly eye (37). In
the fly eye, and in cell culture (51–54), it also was found that
cell death could be suppressed by expression of an N-terminal
DIAP1 fragment containing the two BIR repeats but lacking
the C-terminal RING finger domain. To determine whether
the same fragment of DIAP1 was sufficient to block DCP-1-
dependent cell killing in yeast, we carried out an experiment
in which full length DIAP1, an N-terminal fragment of DIAP1,
or an empty vector was expressed under GALL control in the
presence of GALS-driven DCP-1. As shown in Fig. 5B, inhi-
bition of DCP-1-dependent cell death was seen when DIAP1
or the N-terminal fragment of DIAP1 containing only the
DIAP1 BIR repeats was coexpressed with DCP-1. To deter-
mine whether the observed interaction between DIAP1 and
DCP-1 was direct, we generated bacterially synthesized GST-
DIAP1 as well as His6-tagged versions of prodomainless
DCP-1 (DCP-131-His6) and drICE (drICE81-His6). As shown in
Fig. 6, GST-DIAP1 inhibited DCP-131-His6 caspase activity
but had little if any effect on that of drICE81-His6. Thus, these
results demonstrate that caspase inhibitors can be identified as
FIG. 4. Expression of caspase inhibitors suppresses caspase-
dependent reporter activation in yeast. The LexAyb-gal reporter strain
carrying pGALL-CLBDG6 was transformed with either an empty
pCUP1 plasmid or pCUP1-CED-3 and either an empty pGALL vector
or pGALL-p35. Three colonies from each transformation were grown
for 24 hr in selective galyraf medium. Cultures were diluted 1:10 into
fresh galyraf medium containing 3 mM copper sulfate and were grown
for a further 10 hr, after which o-nitrophenyl-b-D-galactoside assays
for b-gal activity were performed. Cultures from caspase transfor-
mants showed significant b-gal activity, which was suppressed by
GALL-dependent expression of baculovirus p35 (A). In an experi-
ment similar to that described in A, expression of caspase 753 was
induced in cells that express baculovirus p35 or the mouse IAP MIHA.
Expression of caspase 753 resulted in a significant increase in cellular
b-gal activity, which was suppressed by GALL-dependent expression
of p35 or MIHA (B).
FIG. 5. High level expression of the Drosophila caspase DCP-1 kills
yeast and is prevented by coexpression of baculovirus p35 or DIAP1.
EGY48 yeast were transformed with pGALL plasmids containing
either full length DCP-1 (FLDCP-1), an active site C-S mutant of
DCP-1 (DCP-1 C-S), or no insert (vector). Transformants were
streaked from selective glucose-containing medium onto selective
galyraf-inducing medium. Cells expressing either an empty pGALS
vector or the DCP-1 C-S active site mutant grow on galactose-
containing medium whereas cells expressing full length DCP-1 do not
(A). EGY48 yeast carrying pGALS-FLDCP-1 were transformed with
pGALL vectors carrying full length DIAP1 (DIAP1), the DIAP1 BIR
repeats (DIAP1 BIR), baculovirus p35 (p35), or nothing (vector).
GALL-dependent expression of p35, full length DIAP1, and, to a
somewhat lesser extent, the DIAP1 BIR repeats block DCP-1-
dependent cell death (B).
FIG. 6. GST-DIAP1 inhibits the caspase activity of bacterially
synthesized DCP-131-His6, but not drICE81-HIS6. Purified GST-
DIAP1 (0.16 mM) (open triangles) or GST (0.48 mM) (open squares)
was incubated with a fixed amount of DCP-131His6 (0.2nM) in caspase
activity assay buffer containing 100 mM of the Ac-DEVD-AFC
substrate. Release of AFC was monitored fluorometrically over time.
GST-DIAP1 inhibits DCP-1-dependent caspase activity (A). In similar
experiments in which 0.62nM drICE81His6 was incubated in caspase
activity buffer with GST (0.48 mM) or GST-DIAP1, (0.16 mM), no
inhibition of drICE activity by GST-DIAP1was seen (B).
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molecules that block GAL-driven, caspase-dependent cell
death.
Concluding Remarks. We have developed a yeast cell-based
assay for the activity of one group of proteases, the caspases,
in which caspase activity is monitored either by the cleavage-
dependent release of a transcription factor from its transmem-
brane anchor and subsequent activation of a reporter or by
induction of cell killing. Both reporter activation and cell
killing are suppressed by known caspase inhibitors. We have
exploited this fact to directly isolate caspase inhibitors from a
Drosophila embryo cDNA library.
Yeast carrying the transcription-based caspase reporter
should be useful as a background in which to carry out screens
for proteins that cleave a caspase target site and for their
regulators. Because yeast can be transformed with high effi-
ciency, it also constitutes an ideal system in which to carry out
large scale mutagenesis studies of particular proteases or their
regulators. It may also be possible to screen for cellular targets
of specific caspases by using artificial substrate libraries in
which cDNA fragments substitute for the caspase target site
linker in the caspase substrate fusion protein CLBDG6. A
transcription-based reporter strategy similar to that described
here also may provide a way to monitor caspase activity in cells
of higher eukaryotes. Finally, substituting caspase cleavage
sites for those of other site-specific proteases in the CLBDG6
reporter should enable the identification and study of these
proteins and their regulators.
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